-+ 0.00%
-+ 0.00%
-+ 0.00%

AKEBIA THERAPEUTICS - INITIAL DATA FROM PHASE 2 EBRIBAFUSP TRIAL EXPECTED IN 2027

Reuters·09/14/2026 12:00:00

Please log in to view news